Changeflow GovPing Healthcare Prescription Drug Pricing and Adjudication System
Routine Notice Added Final

Prescription Drug Pricing and Adjudication System

Favicon for changeflow.com USPTO Patent Grants - Health Informatics (G16H)
Published
Detected
Email

Summary

USPTO granted Patent US12603165B2 to Rescription, Inc. covering methods and systems for adjudicating prescription drug claims, performing price searches, and conducting 340B eligibility analyses. The patent includes 12 claims and was filed on September 19, 2024. The system enables tracking of prescription and refill information with automated patient notifications about better pricing at different pharmacies.

Published by USPTO on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

USPTO issued Patent US12603165B2 titled 'Prescription drug pricing and adjudication system' to assignee Rescription, Inc. The patent covers computer-implemented methods for adjudicating prescription drug claims, conducting price searches across pharmacies, and performing 340B eligibility analyses. The system can track prescription and refill information for patients and notify them of better pricing options.

Affected parties include healthcare providers, pharmacies, insurers, and employers that process prescription drug claims. Entities developing or operating prescription drug pricing, adjudication, or pharmacy benefit management systems should review this patent to assess potential licensing needs or freedom-to-operate considerations. The patent has 12 claims covering various aspects of the prescription drug pricing and adjudication system.

Archived snapshot

Apr 19, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← USPTO Patent Grants

Prescription drug pricing and adjudication system

Grant US12603165B2 Kind: B2 Apr 14, 2026

Assignee

Rescription, Inc.

Inventors

Gaston Bernstein, Jeremy Dare, Tyler Monson, Richard Vaughn

Abstract

Methods and systems are described for adjudicating prescription drug claims and performing price searches and 340b eligibility analyses. An adjudication system can have connections to patients via computing devices or servers, and similar connections to insurers, medical service providers, pharmacies, employers, government information sources, and other service providers. The adjudication system can track prescription and refill information for a patient, notify the patient of better prices at different pharmacies or medical providers, and automatically schedule doctor appointments when refills are needed.

CPC Classifications

G16H 20/10 G16H 10/60

Filing Date

2024-09-19

Application No.

18889872

Claims

12

View original document →

Get daily alerts for USPTO Patent Grants - Health Informatics (G16H)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from USPTO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
USPTO
Published
April 14th, 2026
Instrument
Notice
Legal weight
Binding
Stage
Final
Change scope
Minor
Document ID
US12603165B2

Who this affects

Applies to
Healthcare providers
Industry sector
5112 Software & Technology
Activity scope
Patent grant Prescription drug claims processing Drug pricing
Geographic scope
United States US

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Healthcare Pharmaceuticals

Get alerts for this source

We'll email you when USPTO Patent Grants - Health Informatics (G16H) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!